Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Mian

Showing results (61-70 of 96) with videos related to

Pageof 10
Sort By:
Urologia Internationalis|June 28, 2014
Comparison of complications from radical cystectomy between old-old versus oldest-old patientsEvi Comploj, Jeremy West, Michael Mian, et al.
British Journal of Haematology|April 15, 2011
Gains of MYC locus and outcome in patients with diffuse large B-cell lymphoma treated with R-CHOPMonica Testoni, Ivo Kwee, Timothy C Greiner, et al.
Leukemia & Lymphoma|June 12, 2010
Patterns of survival of follicular lymphomas at a single institution through three decadesAnnarita Conconi, Maddalena Motta, Francesco Bertoni, et al.
British Journal of Haematology|July 14, 2011
Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemiaAndrea Rinaldi, Michael Mian, Ivo Kwee, et al.
Epidemiology and Infection|October 14, 2021
Prevalence and determinants of serum antibodies to SARS-CoV-2 in the general population of the Gardena valleyRoberto Melotti, Federica Scaggiante, Michela Falciani, et al.
American Journal of Hematology|July 18, 2013
Bendamustine in chronic lymphocytic leukemia: outcome according to different clinical and biological prognostic factors in the everyday clinical practiceFrancesco Zaja, Michael Mian, Stefano Volpetti, et al.
American Journal of Hematology|May 19, 2020
ABVD vs BEACOPP escalated in advanced-stage Hodgkin's lymphoma: Results from a multicenter European studyPatrizia Mondello, Caterina Musolino, Irene Dogliotti, et al.
Hematological Oncology|May 25, 2022
Obinutuzumab does not improve complete methabolic response but does not compromise mobilization or engraftment of autologous peripheral blood stem cells in diffuse large B cell lymphoma: Results from a fondazione italiana linfomi prospective phase II study (the GIOTTO study)Luigi Rigacci, Roberta Battistini, Sofia Kovalchuk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2015
High Doses of Antimetabolites Followed by High-Dose Sequential Chemoimmunotherapy and Autologous Stem-Cell Transplantation in Patients With Systemic B-Cell Lymphoma and Secondary CNS Involvement: Final Results of a Multicenter Phase II TrialAndrés J M Ferreri, Giovanni Donadoni, Maria Giuseppina Cabras, et al.
Leukemia & Lymphoma|February 23, 2011
High response rate and improvement of long-term survival with combined treatment modalities in patients with poor-risk primary thyroid diffuse large B-cell lymphoma: an International Extranodal Lymphoma Study Group and Intergruppo Italiano Linfomi studyMichael Mian, Gianluca Gaidano, Annarita Conconi, et al.
Pageof 10

Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
Urologia Internationalis|June 28, 2014
Comparison of complications from radical cystectomy between old-old versus oldest-old patientsEvi Comploj, Jeremy West, Michael Mian, et al.
British Journal of Haematology|April 15, 2011
Gains of MYC locus and outcome in patients with diffuse large B-cell lymphoma treated with R-CHOPMonica Testoni, Ivo Kwee, Timothy C Greiner, et al.
Leukemia & Lymphoma|June 12, 2010
Patterns of survival of follicular lymphomas at a single institution through three decadesAnnarita Conconi, Maddalena Motta, Francesco Bertoni, et al.
British Journal of Haematology|July 14, 2011
Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemiaAndrea Rinaldi, Michael Mian, Ivo Kwee, et al.
Epidemiology and Infection|October 14, 2021
Prevalence and determinants of serum antibodies to SARS-CoV-2 in the general population of the Gardena valleyRoberto Melotti, Federica Scaggiante, Michela Falciani, et al.
American Journal of Hematology|July 18, 2013
Bendamustine in chronic lymphocytic leukemia: outcome according to different clinical and biological prognostic factors in the everyday clinical practiceFrancesco Zaja, Michael Mian, Stefano Volpetti, et al.
American Journal of Hematology|May 19, 2020
ABVD vs BEACOPP escalated in advanced-stage Hodgkin's lymphoma: Results from a multicenter European studyPatrizia Mondello, Caterina Musolino, Irene Dogliotti, et al.
Hematological Oncology|May 25, 2022
Obinutuzumab does not improve complete methabolic response but does not compromise mobilization or engraftment of autologous peripheral blood stem cells in diffuse large B cell lymphoma: Results from a fondazione italiana linfomi prospective phase II study (the GIOTTO study)Luigi Rigacci, Roberta Battistini, Sofia Kovalchuk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2015
High Doses of Antimetabolites Followed by High-Dose Sequential Chemoimmunotherapy and Autologous Stem-Cell Transplantation in Patients With Systemic B-Cell Lymphoma and Secondary CNS Involvement: Final Results of a Multicenter Phase II TrialAndrés J M Ferreri, Giovanni Donadoni, Maria Giuseppina Cabras, et al.
Leukemia & Lymphoma|February 23, 2011
High response rate and improvement of long-term survival with combined treatment modalities in patients with poor-risk primary thyroid diffuse large B-cell lymphoma: an International Extranodal Lymphoma Study Group and Intergruppo Italiano Linfomi studyMichael Mian, Gianluca Gaidano, Annarita Conconi, et al.
Pageof 10